Bernhard Biersack

Organic Chemistry Laboratory, University of Bayreuth, Bayreuth, Germany.

Research Interests: medicinal chemistry, drug design, epigenetics, metal-based drugs, alkylating agents, tubulin-binding drugs, kinase inhibitors, HDAC inhibitors.

Ilana Chefetz

Hormel Institute, University of Minnesota, Austin, MN, USA.

Research Interests: ovarian cancer, cell death, necroptosis, cancer stem cells, chemoresistance, metabolism, DNA damage and repair, ovary and brain.

Qian Chen

The Fourth People's Hospital Affiliated to Tongji University, Shanghai, China.

Research Interests: nanocatalysis, tumor therapy.

Zhencong Chen

Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.

Research Interests: lung adenocarcinoma, non-small cell lung cancer, drug resistance, thoracic cancer.

Ivy Chung

Department of Pharmacology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.

Research Interests: cancer therapeutics, tumor microenvironment, cancer-associated fibroblasts, drug pharmacology, drug resistance.

Xingliang Dai

Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Research Interests: glioma, nano-medicine, 3D Bioprinting, radio-and chemo-therapy resistance.

Dechao Feng

Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Research Interests: identifying prognostic biomarkers, big data multi-omics analysis, aging, immunology, nanomaterials, drug-related aspects of cancer rehabilitation.

Alessandra Ferraresi

Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.

Research Interests: autophagy, tumor microenvironment, cell metabolism, dormancy, nutraceutics, epigenetics, 3D models, personalized cancer therapy.

Ana Rita Figueiras

Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.

Research Interests: micelleplexes, polymeric micelles, nanomedicine, nanotechnology, gene therapy, cyclodextrins, mucoadhesive polymers.

Natalie R. Gassman

Department of Physiology and Cell Biology, University of South Alabama College of Medicine, Mobile, AL, USA.

Research Interests: triple negative breast cancer, DNA damage, DNA repair, base excision repair.

Xin Hong

Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, China.

Research Interests: circulating tumor cells (CTCs), liquid biopsy, cancer metastasis, non-invasive biomarkers.

Sachi Horibata

Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.

Research Interests: cancer drug resistance, cancer biology, genomics, precision oncology.

Lipeng Hu

Shanghai Jiao Tong University Shanghai Cancer Institute, Shanghai, China.

Research Interests: metabolism reprogramming in tumor microenvironment including tumor cells, stromal cells, immune cells.

Parvez Khan

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.

Research Interests: cancer biology, lung cancer, brain metastasis, chemotherapeutic resistance, cancer therapeutics, cancer metabolism, protein kinases, molecular biophysics, small molecule inhibitors, structure-based drug design and discovery.

JOANNA KOPECKA

Department of Oncology, University of Torino, Torino, Italy.

Research Interests: chemoresistance, immunoresistance, cancer metabolism, stem cells, inflammation, ER stress, new cancer models, new therapeutic approaches.

Yuehua Li

The First Affiliated Hospital, University of South China, Hengyang, Hunan, China.

Research Interests: chest tumor, malignant tumor metastasis, drug resistance.

Xian Lin

Hong Kong University of Science and Technology Medical Center, Peking University, Shenzhen, China.

Research Interests: natural compounds, oncology, immunology, epigenetic modification, signal transduction, bioinformatics, non-coding RNA.

Xiaoxiao Liu

Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.

Research Interests: cancer immunology, gene immunotherapy, anticancer therapy, liver injury and inflammatory.

Alan P Lombard

Department of Urologic Surgery, Department of Biochemistry and Molecular Medicine, School of Medicine, UC Davis, USA.

Research Interests: prostate cancer, therapeutic resistance, treatment response, drug tolerant persistence, PARP inhibition, AR pathway inhibitors, precision medicine, rational combination therapy.

Weiwen Long

Department of Biochemistry and Molecular Biology, Wright State University, Dayton, OH, USA.

Research Interests: growth factor signaling, steroid receptor/coactivator signaling, the interplay between these two signaling pathways in cancer progression and metastasis.

Peng Luo

Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China.

Research Interests: antitumor pharmacogenomics, tumor immune microenvironment.

Li-Ying Ma

School of Pharmacy, Zhengzhou University, Zhengzhou, Henan, China.

Research Interests: targeted drug discovery and mechanism research.

Wei Ma

Jiangnan University, Wuxi, Jiangsu, China.

Research Interests: preparation of nano-biological probes; tumor marker detection and treatment.

Nicola Manfrini

Department of Biosciences, University of Milan, Milan, Italy; National Institute of Molecular Genetics (INGM) “Romeo and Enrica Invernizzi”, Milan, Italy.

Research Interests: cancer biology, cancer drug resistance, autophagy, apoptosis, translation modulation, single-cell analysis, multiple myeloma, breast cancer.

Wenjun Mao

The affiliated Wuxi people’s hospital of Nanjing Medical University, Wuxi, Jiangsu, China.

Research Interests: application of biomaterials in medical field, basic and clinical research of lung cancer, tumor exosomes, tumor immune microenvironment, tumor immunotherapy, tumor biology, bioinformatic.

Elena Mariotto

Department of Woman’s and Child’s Health, University of Padova, Padova, Italy.

Research Interests: high throughput drug screening (HTS), medulloblastoma, acute lymphoblastic leukemia, pediatric cancer, cell cycle, apoptosis, kinase inhibitors.

Chiara Martinelli

Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”, Politecnico di Milano, Milan, Italy.

Research Interests: cancer, theragnostics, targeted therapy, nanotechnology, nanomedicine, multifunctional nanomaterials, nanocarriers, drug delivery.

Cristina Minnelli

Organic Chemistry Laboratory, Department of Life and Environmental Sciences, University Polytechnic of Marche, Ancona, Italy.

Research Interests: lung cancer, epidermal growth factor receptor (EGFR), tyrosine kinase inhibitors (TKIs), structure-based drug design, TKIs resistance, non-small cell lung cancer.

Fu Peng

West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China.

Research Interests: oncology, tumor microenvironment, natural products, non-coding RNA, regulated cell death.

Cristina Pinto Ribeiro Xavier

Cancer Drug Resistance Group, i3S - Instituto de Investigação e Inovação em Saúde, IPATIMUP - Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.

Research Interests: drug discovery, pancreatic cancer, lung cancer, cancer drug resistance, cancer therapy, cancer biology, extracellular vesicles.

Faisal Raza

School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.

Research Interests: cancer, targeted drug delivery, tumor microenvironment, cancer nanomedicine, biomimetic nanotechnology, biomaterials, drug resistance.

Giandomenico Roviello

Department of Health Sciences, University of Florence, Florence, Italy.

Research Interests: immunotherapy, prostate cancer, gastric cancer, renal cell carcinoma, chemotherapy.

Ravi Sahu

Department of Pharmacology and Toxicology, Boonshoft School of Medicine Wright State University, Dayton, OH, USA.

Research Interests: oxidative stressors and lipid mediators, cancer pharmacology and chemoprevention, anti-cancer agents and immunomodulation, cellular signaling pathways in tumor resistance mechanisms.

Iris Chiara Salaroglio

Department of Oncology, University of Turin, Turin, Italy.

Research Interests: MDR, oncology, chemoresistance, immunoresistance, drug response.

Tingyan Shi

Zhongshan Hospital, Fudan University, Shanghai, China.

Research Interests: cervical cancer, ovarian cancer, uterine fibroids, ovarian tumors.

Santosh Singh

Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA, USA.

Research Interests: targeted therapy, nanotherapy, multidrug resistance, drug delivery, combination therapy, prostate cancer, breast cancer, ovarian cancer.

Abhishek Tyagi

Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Research Interests: tumor microenvironment, cancer immunotherapy, breast and lung cancer, tumor metastasis, non-coding RNAs, cancer stem cells and radioresistance.

Hongquan Wang

Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

Research Interests: regulated cell death, cancer drug resistance.

Jingquan Wang

Department of Pharmaceutical Sciences, St. John’s University, Queens, NY, USA.

Research Interests: multidrug resistance, cancer pharmacology, molecular modeling, ABC transporters, drug repurposing, virtual drug screening.

Jingya Wang

Department of Cancer Center, Houston Methodist, Houston, TX, USA.

Research Interests: myltiple myeloma, epigenetics, immunotherapy, cancer immunology, gamma delta T cells, CAR-T.

Ling Wang

School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.

Research Interests: computer-aided drug design, artificial intelligence-aided drug discovery and medicinal chemistry, the design and discovery of kinase inhibitors.

Zheng Wang

Comprehensive Breast Health Center, Ruijin Hospital and Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Research Interests: oncology, cancer metastasis, tumor microenvironment, breast cancer, immunotherapy, metabolic reprogramming, novel target, interventional strategy, clinical pattern, predictive model.

Chenglai Xia

Foshan Maternity and Chlid Healthcare Hospital, Foshan, Guangdong, China.

Research Interests: cancer drug resistance, small-molecule agents for cancer immunotherapy, intratumoral microbiota and drug interactions.

Wen Xiao

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China.

Research Interests: renal cancer, prostate cancer, bladder tumor, tumorigenesis.

Feifei Yang

Henan University of Chinese Medicine, Zhengzhou, Henan, China.

Research Interests: tumor microenvironment, tumor initiation, tumor progression, mechanisms, translational research.

Shen Ying

Department of Pharmacology and Chemical Biology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Research Interests: molecular targeted therapy for lung cancer drug resistance, tumor metastasis, tumor pharmacology, tumor metabolism.

Giorgia Zadra

Institute of Molecular Genetics, National Research Council, Pavia, Italy.

Research Interests: prostate cancer, cancer metabolism, metabolic imaging, metabolomics, diet & lipid metabolism, cancer microenvironment, resistance to endocrine therapies, cancer progression.

Jianye Zhang

School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China.

Research Interests: tumor biology, novel technology application in cancer research, anticancer agents from natural products.

Wei Zhao

Key Laboratory of Stem Cells and Tissue Engineering, Sun Yat-Sen University, Guangzhou, China.

Research Interests: cancer epigenetics, histone modification and RNA methylation in cancers, single-cell analysis of tumor environment.

Xiangxuan Zhao

Department of Radiology, Shengjing Hospital of China Medical University, Liaoning, China.

Research Interests: natural products, cancer resistance, cancer biology, apoptosis, immunotherapy, exosomes, epigenetics.

Fei Zhou

Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.

Research Interests: the discovery of biomarkers, novel therapeutic strategies of immunotherapy and targeted therapy of lung cancer, including patients with rare thoracic cancers, such as pulmonary sarcomotoid carcinoma, pulmonary large cell neuroendocrine carcinoma, et al.